RxDoctor Payments Data

Eric Houpt

Infectious Disease · Charlottesville, VANPI 1720157332

Payments from drug & device makers

What this record shows

That places this record below the midpoint for infectious disease clinicians in VA, where the typical reported total is $169.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$448,720in research payments, 2019–2025

Across 80 payments — averaging $5609.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Mannkind Corporation$318K
  • Insmed, Inc.$131K

How this compares

$0 in reported general payments places this provider in the 15th percentile of 194 infectious disease providers in Virginia.

See all infectious disease providers in Virginia

Medicare billing

Part B allowed, 2024
$20,494
Medicare patients
94
Services billed
168

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ArikayceAmikacin Liposomal/Neb.Accessr16$244,958
Ethambutol Hcl84$4,048
Rifampin66$3,852
Azithromycin103$2,093
Amikacin Sulfate13$322
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$214
Pantoprazole Sodium17$213

Paid to pharmacies, not to this prescriber.

Other infectious disease in Charlottesville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →